Lupin Limited is a pharmaceutical company headquartered in Mumbai, India. The company was founded in 1968 and has operations in over 100 countries. Lupin is primarily engaged in the development, manufacture, and marketing of generic and branded pharmaceuticals, biosimilars, and specialty pharmaceuticals.
The company has a diversified portfolio of products across therapeutic areas such as cardiovascular, diabetes, respiratory, central nervous system, gastroenterology, and women’s health. Lupin has a strong focus on research and development, with significant investments in developing innovative products and drug delivery technologies. In terms of earnings, Revenue from Operations for Q3 FY23 was ₹4,244.56 crore, a 4% increase from ₹4,087.48 crore in the same period last year. The third quarter’s other income, which contributed ₹77.66 Crore to the Total Revenue. Meanwhile, the Profit Before Tax improved to ₹246.14 Crore from ₹167 Crore from the same quarter previous year. The Consolidated Net Profit was ₹157.65 crore, significantly down from ₹549 crore in the same quarter last year. This quarter’s earnings per share was ₹3.36.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,